Johnson & Johnson JNJB34.SA Stock
Johnson & Johnson Price Chart
Johnson & Johnson JNJB34.SA Financial and Trading Overview
Johnson & Johnson stock price | 53.01 BRL |
Previous Close | 50.31 BRL |
Open | 0 BRL |
Bid | 50.5 BRL x 0 |
Ask | 51.2 BRL x 0 |
Day's Range | 0 - 0 BRL |
52 Week Range | 0 - 65.5 BRL |
Volume | 0 BRL |
Avg. Volume | 12.96K BRL |
Market Cap | 1.84T BRL |
Beta (5Y Monthly) | 0.573 |
PE Ratio (TTM) | 29.045715 |
EPS (TTM) | 1.73 BRL |
Forward Dividend & Yield | 1.43 (2.81%) |
Ex-Dividend Date | November 20, 2023 |
1y Target Est | N/A |
JNJB34.SA Valuation Measures
Enterprise Value | 130.03B BRL |
Trailing P/E | 29.045715 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 18.618105 |
Price/Book (mrq) | 1.7178102 |
Enterprise Value/Revenue | 1.318 |
Enterprise Value/EBITDA | 3.714 |
Trading Information
Johnson & Johnson Stock Price History
Beta (5Y Monthly) | 0.573 |
52-Week Change | N/A |
S&P500 52-Week Change | N/A |
52 Week High | 65.5 BRL |
52 Week Low | 0 BRL |
50-Day Moving Average | 50.27 BRL |
200-Day Moving Average | 52.58 BRL |
JNJB34.SA Share Statistics
Avg. Volume (3 month) | 12.96K BRL |
Avg. Daily Volume (10-Days) | 8.05K BRL |
Shares Outstanding | 36.11B |
Float | 2.4B |
Short Ratio | N/A |
% Held by Insiders | 0% |
% Held by Institutions | 0.0020% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 4.64 |
Trailing Annual Dividend Yield | 9.22% |
5 Year Average Dividend Yield | 238.00% |
Payout Ratio | 0.8561 |
Last Split Factor | 15:1 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | January 1, 2023 |
Most Recent Quarter (mrq) | October 1, 2023 |
Next Fiscal Year End | January 1, 2024 |
Profitability
Profit Margin | 35.09% |
Operating Margin (ttm) | 30.07% |
Gross Margin | 67.55% |
EBITDA Margin | 35.49% |
Management Effectiveness
Return on Assets (ttm) | 10.11% |
Return on Equity (ttm) | 19.18% |
Income Statement
Revenue (ttm) | 98.66B BRL |
Revenue Per Share (ttm) | 2.56 BRL |
Quarterly Revenue Growth (yoy) | 6.80% |
Gross Profit (ttm) | 63.95B BRL |
EBITDA | 35.01B BRL |
Net Income Avi to Common (ttm) | 13.99B BRL |
Diluted EPS (ttm) | 1.75 |
Quarterly Earnings Growth (yoy) | 483.80% |
Balance Sheet
Total Cash (mrq) | 23.51B BRL |
Total Cash Per Share (mrq) | 9.77 BRL |
Total Debt (mrq) | 29.92B BRL |
Total Debt/Equity (mrq) | 42.01 BRL |
Current Ratio (mrq) | 1.21 |
Book Value Per Share (mrq) | 29.59 |
Cash Flow Statement
Operating Cash Flow (ttm) | 20.28B BRL |
Levered Free Cash Flow (ttm) | 21.17B BRL |
Profile of Johnson & Johnson
Country | Brazil |
State | NJ |
City | New Brunswick |
Address | One Johnson & Johnson Plaza |
ZIP | 08933 |
Phone | 732 524 0400 |
Website | https://www.jnj.com |
Industry | Drug Manufacturers-General |
Sector(s) | Healthcare |
Full Time Employees | 152700 |
Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment provides skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. This segment also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment provides products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes, and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment offers electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and contact lenses and ophthalmic technologies related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.
Q&A For Johnson & Johnson Stock
What is a current JNJB34.SA stock price?
Johnson & Johnson JNJB34.SA stock price today per share is 53.01 BRL.
How to purchase Johnson & Johnson stock?
You can buy JNJB34.SA shares on the São Paulo exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Johnson & Johnson?
The stock symbol or ticker of Johnson & Johnson is JNJB34.SA.
Which industry does the Johnson & Johnson company belong to?
The Johnson & Johnson industry is Drug Manufacturers-General.
How many shares does Johnson & Johnson have in circulation?
The max supply of Johnson & Johnson shares is 36.15B.
What is Johnson & Johnson Price to Earnings Ratio (PE Ratio)?
Johnson & Johnson PE Ratio is 30.64161700 now.
What was Johnson & Johnson earnings per share over the trailing 12 months (TTM)?
Johnson & Johnson EPS is 1.73 BRL over the trailing 12 months.
Which sector does the Johnson & Johnson company belong to?
The Johnson & Johnson sector is Healthcare.